IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

VIGANO', OTTAVIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.507
EU - Europa 1.229
AS - Asia 945
SA - Sud America 168
AF - Africa 33
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 3.891
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.445
GB - Regno Unito 373
CN - Cina 323
SG - Singapore 313
IT - Italia 176
DE - Germania 166
SE - Svezia 140
BR - Brasile 136
HK - Hong Kong 84
RU - Federazione Russa 79
NL - Olanda 60
CA - Canada 56
IN - India 50
UA - Ucraina 49
FR - Francia 47
TR - Turchia 45
FI - Finlandia 37
IE - Irlanda 37
KR - Corea 34
EU - Europa 26
BE - Belgio 19
ID - Indonesia 19
VN - Vietnam 16
CI - Costa d'Avorio 15
JP - Giappone 14
CO - Colombia 12
GR - Grecia 10
ZA - Sudafrica 8
DK - Danimarca 7
ES - Italia 6
AR - Argentina 5
AT - Austria 5
AU - Australia 5
MX - Messico 5
CL - Cile 4
IL - Israele 4
IQ - Iraq 4
TH - Thailandia 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
JO - Giordania 3
MA - Marocco 3
OM - Oman 3
PK - Pakistan 3
PL - Polonia 3
AM - Armenia 2
BD - Bangladesh 2
BG - Bulgaria 2
CH - Svizzera 2
IR - Iran 2
KE - Kenya 2
KH - Cambogia 2
LB - Libano 2
LK - Sri Lanka 2
PE - Perù 2
PH - Filippine 2
PS - Palestinian Territory 2
PY - Paraguay 2
RO - Romania 2
SA - Arabia Saudita 2
TW - Taiwan 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BH - Bahrain 1
CM - Camerun 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
GA - Gabon 1
KZ - Kazakistan 1
LU - Lussemburgo 1
LV - Lettonia 1
ME - Montenegro 1
MW - Malawi 1
NC - Nuova Caledonia 1
NO - Norvegia 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
Totale 3.915
Salva come PNG Salva come JPEG
Città #
Southend 326
Ashburn 188
Singapore 169
Chandler 144
Fairfield 79
Hong Kong 79
Milan 76
Beijing 70
Ann Arbor 67
Dallas 62
Woodbridge 62
Seattle 56
Wilmington 50
Houston 45
Princeton 43
Santa Clara 43
Dearborn 38
Dublin 37
Council Bluffs 36
Los Angeles 32
Toronto 29
Cambridge 28
Jacksonville 28
Munich 26
Redmond 24
Boardman 19
Brussels 19
Buffalo 19
Frankfurt am Main 18
Jakarta 18
Hefei 17
Montreal 17
Bengaluru 16
Nanjing 16
Somerville 16
Helsinki 14
Mountain View 14
Sakarya 14
São Paulo 13
Abidjan 12
Columbus 12
Phoenix 12
Andover 11
Bogotá 11
Cangzhou 11
Des Moines 11
Tokyo 11
Athens 10
Guangzhou 10
Redwood City 10
Seoul 10
Shanghai 10
Tianjin 10
San Jose 9
The Dalles 9
Turin 9
Grafing 8
Ho Chi Minh City 8
Kent 8
New York 8
Serra 8
Jinan 7
Moscow 7
Hebei 6
Margão 6
Nürnberg 6
Padova 6
Porto Alegre 6
Rome 6
Silver Spring 6
Belo Horizonte 5
Mumbai 5
Nanchang 5
Orem 5
Quanzhou 5
San Francisco 5
Shenyang 5
Turku 5
Wuhan 5
Yubileyny 5
Berlin 4
Changsha 4
Chicago 4
Eitensheim 4
Fuzhou 4
Istanbul 4
Johannesburg 4
Paris 4
San Diego 4
Amman 3
Auburn Hills 3
Boston 3
Brasília 3
Brooklyn 3
Dongguan 3
Falls Church 3
Florence 3
Fremont 3
Haiphong 3
Jiaxing 3
Totale 2.460
Salva come PNG Salva come JPEG
Nome #
Evolution of the HIV-1 protease region in heavily pretreated HIV-1 infected patients receiving Atazanavir 292
Comparative evaluation of seven resistance interpretation algorithms and their derived genotypic inhibitory quotients for the prediction of 48 week virological response to darunavir-based salvage regimens 290
Abacavir hypersensitivity reaction after switching from the twice-daily to the once-daily formulation 276
Does GSS Still Maintain Relevance on HAART Outcome After the Introduction of Newest Active Antiretroviral Drugs? 48 Weeks Results 251
Efficacy and safety of a dual boosted protease inhibitor-based regimen, atazanavir and fosamprenavir/ritonavir, against HIV : experience in a pediatric population 244
Analysis of protease inhibitor combinations in vitro : activity of lopinavir, amprenavir and tipranavir against HIV type 1 wild-type and drug-resistant isolates 236
New macrocyclic amines showing activity as HIV entry inhibitors against wild type and multi-drug resistant viruses 230
Efficacia di Caspofungin nella candidosi esofagea HIV-correlata multifarmacoresistente 226
Unusual codon 69 insertions : influence on human immunodeficiency virus type 1 reverse transcriptase drug susceptibility 220
Absence of new thymidine-associated mutations and evidence of an immune virologic response over a 12-month period in a cohort of antiretroviral- experienced HIV-1-infected subjects treated with tenofovir combination therapy [2] 205
Predictive factors of therapeutic success of a HAART regimen including atazanavir with or without ritonavir in HIV-infected patients 191
Successful rescue therapy with Raltegravir (MK-0518) and Etravirine (TMC125) in an HIV-infected patient failing all four classes of antiretroviral drugs 173
Switching to unboosted atazanavir reduces bilirubin and triglycerides without compromising treatmentefficacy in UGT1A1*28 polymorphism carriers 167
Female gender is associated with long COVID syndrome : a prospective cohort study 150
Efficacy, tolerability and virological consequences of long-term use of unboosted atazanavir plus 2 NRTIs in HIV-infected patients 146
Real World Estimate of Vaccination Protection in Individuals Hospitalized for COVID-19 141
New HIV protease inhibitors for drug-resistant viruses 136
Haemoptysis and fever in a young refugee from Somalia 131
Successful pharmacogenetics-based optimization of unboosted atazanavir plasma exposure in HIV-positive patients : a randomized, controlled, pilot study (the REYAGEN study) 126
Resolution of multidrug-refractory oesophageal candidiasis in an AIDS patient after treatment with caspofungin 118
Three case reports of West Nile virus neuroinvasive disease: lessons from real-life clinical practice 106
null 3
Totale 4.058
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.874
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.874
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021186 0 0 0 0 0 0 17 21 41 19 67 21
2021/2022265 33 9 11 9 14 11 20 22 50 26 11 49
2022/2023409 41 46 39 53 33 86 6 33 51 2 15 4
2023/2024232 13 20 16 29 38 13 17 14 3 11 19 39
2024/2025750 18 54 12 93 70 36 67 58 52 73 70 147
2025/2026720 161 126 144 96 113 80 0 0 0 0 0 0
Totale 4.058